Correlation Between BellRock Brands and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BellRock Brands and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BellRock Brands and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BellRock Brands and Bionoid Pharma, you can compare the effects of market volatilities on BellRock Brands and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BellRock Brands with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BellRock Brands and Bionoid Pharma.

Diversification Opportunities for BellRock Brands and Bionoid Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BellRock and Bionoid is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BellRock Brands and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and BellRock Brands is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BellRock Brands are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of BellRock Brands i.e., BellRock Brands and Bionoid Pharma go up and down completely randomly.

Pair Corralation between BellRock Brands and Bionoid Pharma

Assuming the 90 days horizon BellRock Brands is expected to under-perform the Bionoid Pharma. But the pink sheet apears to be less risky and, when comparing its historical volatility, BellRock Brands is 1.25 times less risky than Bionoid Pharma. The pink sheet trades about -0.22 of its potential returns per unit of risk. The Bionoid Pharma is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  10.00  in Bionoid Pharma on September 14, 2024 and sell it today you would earn a total of  17.00  from holding Bionoid Pharma or generate 170.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BellRock Brands  vs.  Bionoid Pharma

 Performance 
       Timeline  
BellRock Brands 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BellRock Brands has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Bionoid Pharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

BellRock Brands and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BellRock Brands and Bionoid Pharma

The main advantage of trading using opposite BellRock Brands and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BellRock Brands position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind BellRock Brands and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamental Analysis
View fundamental data based on most recent published financial statements